JP2024517027A5 - - Google Patents
Info
- Publication number
- JP2024517027A5 JP2024517027A5 JP2023569935A JP2023569935A JP2024517027A5 JP 2024517027 A5 JP2024517027 A5 JP 2024517027A5 JP 2023569935 A JP2023569935 A JP 2023569935A JP 2023569935 A JP2023569935 A JP 2023569935A JP 2024517027 A5 JP2024517027 A5 JP 2024517027A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- cdr
- chain variable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SG10202104940X | 2021-05-11 | ||
| SG10202104940X | 2021-05-11 | ||
| PCT/SG2022/050308 WO2022240360A1 (en) | 2021-05-11 | 2022-05-11 | Chimeric antigen receptors and modified cells comprising the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024517027A JP2024517027A (ja) | 2024-04-18 |
| JP2024517027A5 true JP2024517027A5 (https=) | 2025-05-19 |
Family
ID=84029911
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023569935A Pending JP2024517027A (ja) | 2021-05-11 | 2022-05-11 | キメラ抗原受容体及びそれを含む改変細胞 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240252536A1 (https=) |
| EP (1) | EP4337684A4 (https=) |
| JP (1) | JP2024517027A (https=) |
| KR (1) | KR20240007204A (https=) |
| CN (1) | CN117616039A (https=) |
| AU (1) | AU2022271707A1 (https=) |
| CA (1) | CA3215528A1 (https=) |
| MX (1) | MX2023013296A (https=) |
| WO (1) | WO2022240360A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3186753A1 (en) | 2020-07-20 | 2022-01-27 | John Mumm | Dual cytokine fusion proteins comprising il-10 |
| CA3244604A1 (en) | 2022-02-22 | 2023-08-31 | Deka Biosciences, Inc. | METHOD FOR REDUCING A BISPECIFIC T LYMPHOCYTE RECRUITER OR A CHIMERICAL ANTIGEN RECEPTOR T LYMPHOCYTE CYTOKINE RELEASE SYNDROME USING INTERLEUKIN 4 OR 10, OR AN ASSOCIATED FUSION PROTEIN |
| WO2024128219A1 (ja) * | 2022-12-13 | 2024-06-20 | 愛知県 | キメラ抗原受容体 |
| CN116874596B (zh) * | 2023-09-06 | 2023-11-24 | 南京佰抗生物科技有限公司 | 抗S100β蛋白的单克隆抗体及其制备方法和应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018057585A1 (en) * | 2016-09-21 | 2018-03-29 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Chimeric antigen receptor (car) that targets chemokine receptor ccr4 and its use |
| US11788093B2 (en) * | 2017-09-07 | 2023-10-17 | University Of Florida Research Foundation, Inc. | Chimeric antigen receptor t-cells expressing interleukin-8 receptor |
| JP7296133B2 (ja) * | 2018-03-16 | 2023-06-22 | 国立大学法人信州大学 | 遺伝子改変細胞及びその作製方法 |
| JP7334985B2 (ja) * | 2018-04-02 | 2023-08-29 | ナショナル ユニヴァーシティー オブ シンガポール | 免疫細胞で発現される膜結合抗サイトカイン非シグナル伝達バインダーによるヒトサイトカインの中和 |
| EP3781176A4 (en) * | 2018-04-09 | 2022-05-25 | The Trustees of the University of Pennsylvania | METHODS AND COMPOSITIONS USING A VIRAL VECTOR FOR THE EXPRESSION OF A TRANSGENE AND AN EFFECTOR |
| KR102088789B1 (ko) * | 2018-06-20 | 2020-03-13 | 인하대학교 산학협력단 | 항 TNF/IFN scFv-Fc 이중 표적 항체 및 이의 이용 |
| IL317193A (en) * | 2022-05-24 | 2025-01-01 | Leibniz Inst F?R Immuntherapie Lit | Artificial immune system receptors |
| CN118005804A (zh) * | 2024-01-29 | 2024-05-10 | 北京医院 | 一种响应致炎细胞因子的CAR序列和CAR-Treg细胞的构建方法及应用 |
-
2022
- 2022-05-11 CA CA3215528A patent/CA3215528A1/en active Pending
- 2022-05-11 JP JP2023569935A patent/JP2024517027A/ja active Pending
- 2022-05-11 EP EP22807955.4A patent/EP4337684A4/en active Pending
- 2022-05-11 AU AU2022271707A patent/AU2022271707A1/en active Pending
- 2022-05-11 MX MX2023013296A patent/MX2023013296A/es unknown
- 2022-05-11 CN CN202280044507.XA patent/CN117616039A/zh active Pending
- 2022-05-11 KR KR1020237042205A patent/KR20240007204A/ko active Pending
- 2022-05-11 US US18/290,242 patent/US20240252536A1/en active Pending
- 2022-05-11 WO PCT/SG2022/050308 patent/WO2022240360A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024517027A5 (https=) | ||
| JP2019516352A5 (https=) | ||
| JP2022523781A5 (https=) | ||
| JP2020513839A5 (https=) | ||
| AU2017301880B2 (en) | Immunomodulatory polypeptides and related compositions and methods | |
| JP2021000103A5 (https=) | ||
| HRP20221348T1 (hr) | Kimerni receptori i postupci njihove uporabe | |
| HRP20251135T1 (hr) | Postupci dobivanja kimernih stanica koje eksprimiraju antigenske receptore | |
| CA3111087A1 (en) | Anti-mesothelin chimeric antigen receptor (car) constructs and uses thereof | |
| JP2019515661A5 (https=) | ||
| CA3032054A1 (en) | Combination therapies of chimeric antigen receptors and pd-1 inhibitors | |
| JP2022530773A5 (https=) | ||
| JP2021530233A5 (https=) | ||
| JP2017524367A5 (https=) | ||
| JP2023518930A5 (https=) | ||
| US20240067955A1 (en) | Methods for high throughput screening of chimeric antigen receptors | |
| JP2024539506A5 (https=) | ||
| RU2019128921A (ru) | Антитело к il-13ra2 и его применение | |
| JP2022538425A5 (https=) | ||
| JP2025511409A5 (https=) | ||
| JP2025513427A5 (https=) | ||
| WO2021127212A2 (en) | Systems and methods for producing efficacious regulatory t cells | |
| KR20240007204A (ko) | 키메라 항원 수용체 및 이를 포함하는 변형된 세포 | |
| CN120035658A (zh) | Nkg2d工程化细胞及其组合物 | |
| JP2023518931A5 (https=) |